PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1954652
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1954652
The global spirometer market size was valued at USD 679.85 million in 2025. The market is projected to grow from USD 716.61 million in 2026 to USD 1,122.92 million by 2034, exhibiting a CAGR of 6.63% during the forecast period (2026-2034).
North America dominated the spirometer market with a 50.46% market share in 2025, supported by high respiratory disease prevalence and strong healthcare infrastructure.
A spirometer is a diagnostic medical device used to measure lung function by assessing the volume of air inhaled and exhaled. It plays a crucial role in diagnosing and managing respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. According to the Forum of International Respiratory Societies (2023), around 334 million people suffer from asthma globally, and more than 65 million people are affected by COPD, highlighting the growing demand for spirometry devices.
Although the COVID-19 pandemic negatively impacted the market due to temporary closures of pulmonary function testing (PFT) labs, recovery began in 2021-2022 with the reopening of healthcare facilities and rising demand for respiratory diagnostics.
SPIROMETER MARKET TRENDS
Growing Investment in Smart and Connected Devices
Rising investments in digital health and connected spirometry solutions are driving market growth. Companies are developing Bluetooth-enabled and AI-integrated spirometers for remote monitoring.
For instance, in January 2023, Aluna secured USD 15.3 million in Series B funding to expand its app-connected spirometry solution for asthma, COPD, and cystic fibrosis management. Similarly, partnerships such as Clario and ArtiQ (March 2023) are enhancing AI-driven spirometry data analysis in clinical trials.
The adoption of smart spirometers has shown a reduction in emergency visits and hospitalizations related to asthma, further strengthening product demand.
MARKET GROWTH FACTORS
Increasing Technological Advancements
Technological innovation is a key growth driver. Portable, handheld, and user-friendly spirometry devices have addressed underutilization challenges. In January 2020, NuvoAir's connected spirometer received FDA approval in the U.S., enabling remote lung monitoring.
Artificial intelligence integration is further improving diagnostic accuracy and treatment optimization. Continuous R&D investments are expected to support early COPD detection and improve disease management outcomes.
Rising Prevalence of COPD
COPD is the third leading cause of death worldwide. According to the National Heart, Lung, and Blood Institute (2022), approximately 16 million Americans suffer from COPD. Smoking, pollution, and environmental exposures are major contributors. The growing global burden of respiratory diseases is significantly boosting demand for spirometry testing.
RESTRAINING FACTORS
Shortage of Skilled Professionals
A major limitation is the shortage of trained pulmonary function technologists. According to WHO (2023), there could be a shortfall of 10 million healthcare workers by 2030, particularly in low-income countries. Limited skilled workforce and lack of awareness in developing regions may restrict device adoption.
SEGMENTATION ANALYSIS
By Product Type
The market is segmented into devices, software, and accessories & consumables.
By Type
The market includes volume measurement spirometers and peak flow meters.
By Application
Segments include COPD, asthma, and others.
By End User
The market is segmented into hospitals, diagnostic centers, homecare settings, clinics, and others.
REGIONAL INSIGHTS
North America
North America recorded a market size of USD 343.07 million in 2025 and held a dominant 50.46% share. High COPD and asthma prevalence, strong regulatory support, and presence of major players drive regional growth. The U.S. market is projected to reach USD 324.53 million in 2026.
Europe
Europe is projected to grow steadily due to increasing awareness and regulatory approvals. The UK market is projected to reach USD 37.73 million in 2026, while Germany is expected to reach USD 24.12 million in 2026.
Asia Pacific
Asia Pacific is anticipated to witness strong growth due to increasing investments and product launches. The Japan market is projected to reach USD 19.4 million in 2026, China USD 26.85 million, and India USD 25.08 million.
Rest of the World
Latin America and the Middle East & Africa hold comparatively smaller shares but are improving through training programs and awareness campaigns.
COMPETITIVE LANDSCAPE
Key companies include ndd Medizintechnik AG, COSMED srl, MGC Diagnostics, Morgan Scientific, VYAIRE, Ganshorn, and MIR. Strategic collaborations, acquisitions, and AI integration initiatives are strengthening competitive positioning. For example, CAIRE Inc. acquired MGC Diagnostics in January 2023 to expand its respiratory diagnostics portfolio.
CONCLUSION
The global spirometer market is set to grow steadily from USD 679.85 million in 2025 to USD 716.61 million in 2026, reaching USD 1,122.92 million by 2034 at a CAGR of 6.63%. Growth is primarily driven by the increasing prevalence of COPD and asthma, technological advancements in portable and AI-enabled spirometry devices, and expanding home healthcare adoption.
North America remains the leading region with a 50.46% share in 2025, while Asia Pacific is emerging as a high-growth market. Although workforce shortages and limited awareness in developing countries pose challenges, rising investments, regulatory support, and digital health integration are expected to unlock long-term opportunities.
Segmentation By Product Type
By Type
By Application
By End User
By Region